BTK inhibitors are a possible emerging therapeutic target for gastric cancer

BTK inhibitors are a possible emerging therapeutic target for gastric cancer

Saved in:

Bibliographic Details
Main Authors:	José Darío Portillo-Miño, Jhon Jairo Calderon, Arnoldo Riquelme
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Molecular Therapy: Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950329925000049
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM)
by: Sze-Ting Bong, et al.
Published: (2019-05-01)

Myokines as Possible Therapeutic Targets in Cancer Cachexia
by: Emilia Manole, et al.
Published: (2018-01-01)

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
by: Mikito Inokuchi, et al.
Published: (2015-01-01)

A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
by: Steven P. Treon, et al.
Published: (2025-01-01)

Role of the Btk-PLCγ2 Signaling Pathway in the Bone Destruction of Apical Periodontitis
by: Lina Wang, et al.
Published: (2019-01-01)

The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets
by: M. Isabel Palacios-Arreola, et al.
Published: (2014-01-01)

The Possible Potential Therapeutic Targets for Drug Induced Gingival Overgrowth
by: Tamilselvan Subramani, et al.
Published: (2013-01-01)

The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
by: Nada H. Aljarba, et al.
Published: (2025-03-01)

COX-2 Inhibitors and Gastric Cancer
by: Zhen Wang, et al.
Published: (2014-01-01)

Emerging Lung Cancer Therapeutic Targets Based on the Pathogenesis of Bone Metastases
by: Moses O. Oyewumi, et al.
Published: (2014-01-01)

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
by: Ahmad Hamad, et al.
Published: (2013-01-01)

The Enteric Nervous System and Its Emerging Role as a Therapeutic Target
by: Mark A. Fleming, et al.
Published: (2020-01-01)

Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches
by: Lucia Centanni, et al.
Published: (2025-01-01)

Dual targeting carbonic anhydrase inhibitors as promising therapeutic approach: a structural overview
by: Katia D’Ambrosio, et al.
Published: (2025-02-01)

Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application
by: Kaichun Li, et al.
Published: (2016-01-01)

Sonic Hedgehog Signaling Drives Proliferation of Synoviocytes in Rheumatoid Arthritis: A Possible Novel Therapeutic Target
by: Mingxia Wang, et al.
Published: (2014-01-01)

Repurposing of phosphodiesterase-5 inhibitor sildenafil as a therapeutic agent to prevent gastric cancer growth through suppressing c-MYC stability for IL-6 transcription
by: Zhenzhan Zhang, et al.
Published: (2025-01-01)

The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics
by: Diana M. Norden, et al.
Published: (2024-12-01)

NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
by: Heng Wu, et al.
Published: (2025-01-01)

Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
by: Dingtian Luo, et al.
Published: (2025-02-01)

Multivariate Cox regression analysis of prognostic genes and therapeutic mechanisms of gastric cancer
by: Yangyang Xiao, et al.
Published: (2025-02-01)

Characterization of Bozitinib as a potential therapeutic agent for MET-amplified gastric cancer
by: Hang Lin, et al.
Published: (2025-01-01)

Hijacking of the nervous system in cancer: mechanism and therapeutic targets
by: Yu Zhang, et al.
Published: (2025-02-01)

Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer
by: Meena K. Sakharkar, et al.
Published: (2013-01-01)

Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
by: Ding Nan, et al.
Published: (2025-01-01)

Emergences and possibilities about of University Research and Innovation
by: Teresa García Gómez, et al.
Published: (2009-12-01)

Schiff bases and their possible therapeutic applications: A review
by: Nidhi, et al.
Published: (2025-01-01)

A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease
by: Shankar J. Chinta, et al.
Published: (2012-01-01)

Emerging Nanoparticle-Based Diagnostics and Therapeutics for Cancer: Innovations and Challenges
by: Rachitha Puttasiddaiah, et al.
Published: (2025-01-01)

Screening of Active Components and Key Targets of Radix Codonopsis in the Treatment of Gastric Cancer
by: Lijun Tang, et al.
Published: (2021-01-01)

Gastric antral vascular ectasia. Clinical presentation and therapeutic management
by: Nélcido Luis Sánchez García, et al.
Published: (2018-10-01)

The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells
by: Sabrina Bimonte, et al.
Published: (2016-01-01)

PPARγ as a Novel Therapeutic Target in Lung Cancer
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

Emerging therapeutics in idiopathic inflammatory myopathy
by: Shinji Sato
Published: (2020-01-01)

Cell-Specific Aptamers as Emerging Therapeutics
by: Cindy Meyer, et al.
Published: (2011-01-01)

The Emerging Role of GC-MSCs in the Gastric Cancer Microenvironment: From Tumor to Tumor Immunity
by: Zhaoji Pan, et al.
Published: (2019-01-01)

New Therapeutic Targets for Mood Disorders
by: Rodrigo Machado-Vieira, et al.
Published: (2010-01-01)

EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer
by: Yongbin Zheng, et al.
Published: (2025-02-01)

Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses
by: Thomas J. Baric, et al.
Published: (2024-12-01)

PROTAC-based therapeutics for targeting HPV oncoproteins in head and neck cancers
by: Nobendu Mukerjee, et al.
Published: (2025-12-01)